GSK Stock Ownership Activity

GLAXOSMITHKLINE PLC-SPON ADR 13F holders

1 value investing guru has made changes to the GLAXOSMITHKLINE PLC-SPON ADR (GSK) position according to the gurus' latest SEC quarterly report(s). The number of GSK shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying GSK now?

According to the latest SEC filing(s) GLAXOSMITHKLINE PLC-SPON ADR (GSK) has not been purchased by any super investor.

To see more about who is investing in GLAXOSMITHKLINE PLC-SPON ADR (GSK), please go to the GSK ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2016 Q1 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+55.97%
+37,880
+0.36%
1.00%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-12.81%
-9,891
-0.02%
0.09%
Sarah Ketterer
Causeway Capital Management
-13.10%
-54,296
-0.07%
0.44%
Current price: $34.12 33.97% AVG reported price*: $51.67
2015 Q4 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+47.13%
+21,680
+0.20%
0.61%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.25%
-267
-0.00%
0.16%
Sarah Ketterer
Causeway Capital Management
-14.52%
-70,432
-0.08%
0.44%
Current price: $34.12 32.35% AVG reported price*: $50.44
2015 Q3 (3 results)
Sarah Ketterer
Causeway Capital Management
+19.44%
+78,947
+0.08%
0.47%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
+4.03%
+4,138
+0.01%
0.15%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-1.20%
-369
-0.00%
0.27%
Current price: $34.12 29.01% AVG reported price*: $48.06
2015 Q2 (2 results)
Sarah Ketterer
Causeway Capital Management
+15.47%
+54,414
+0.07%
0.53%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-2.33%
-2,449
-0.00%
0.15%
Current price: $34.12 34.46% AVG reported price*: $52.06
2015 Q1 (3 results)
Sarah Ketterer
Causeway Capital Management
buy
+351,691
+0.53%
0.53%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+14.12%
+5,760
+0.06%
0.45%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-2.19%
-1,614
-0.00%
0.11%
Current price: $34.12 40.85% AVG reported price*: $57.69
2014 Q4 (1 result)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-4.27%
-4,788
-0.01%
0.15%
Current price: $34.12 36.14% Reported price*: $53.43
2014 Q3 (2 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
buy
+40,800
+0.38%
0.38%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.29%
-1,472
-0.00%
0.15%
Current price: $34.12 40.62% AVG reported price*: $57.46
2014 Q2 (1 result)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.34%
-384
-0.00%
0.16%
Current price: $34.12 48.96% Reported price*: $66.85
2014 Q1 (1 result)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-5.05%
-6,069
-0.01%
0.18%
Current price: $34.12 48.91% Reported price*: $66.79
2013 Q4 (3 results)
Francis Chou
Chou Associates Management
buy
+12,240
+0.14%
0.12%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.56%
-677
-0.00%
0.19%
Warren Buffett
Berkshire Hathaway
-100.00%
-276,655
-0.02%
0.00%
Current price: $34.12 31.71% AVG reported price*: $49.96
2013 Q3 (2 results)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-0.04%
-48
-0.00%
0.18%
Warren Buffett
Berkshire Hathaway
-76.57%
-904,162
-0.06%
0.00%
Current price: $34.12 45.59% AVG reported price*: $62.71
2013 Q2 (2 results)
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
buy
+120,872
+0.19%
0.19%
Warren Buffett
Berkshire Hathaway
buy
+684,873
+0.08%
0.05%
Current price: $34.12 45.38% AVG reported price*: $62.46
26 of 122

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.